We are down to just 16 teams in the 2026 Women’s Basketball Tournament, and that means it’s time for the stars to show what they are capable of. Depth and role-players are important, but with the field narrowed to this point, it’s stars that will carry the day. Here is the top player from each…
A man walks at a supermarket in Houston, Texas, on March 17, 2026. Ronaldo Schemidt | AFP | Getty Images Surging energy prices, rising import costs and mounting stagflation concerns are pushing markets to consider that the Federal Reserve’s next move could be a rate hike. Traders in the futures market pushed the probability of…
This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and…
Nikolas Kokovlis | Nurphoto | Getty Images Elon Musk’s xAI and its chatbot Grok have been banned from creating non-consensual AI-generated images of adults and children by a Dutch court, adding to growing legal pressure on the company. Amsterdam’s District Court issued a legal order on Thursday prohibiting xAI from generating and distributing sexual imagery…
TripAdvisor is poised to grow as activist investors step up pressure on the travel booking company to adopt a more fluid, active strategy to fuel growth, according to Bank of America. The bank’s research arm upgraded TripAdvisor to buy from neutral and raised its 12-month price target on the stock to $15 from $14. That…
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Major luxury stocks have fallen 15% or more since the Iran war started, and sales in the increasingly important Middle East market could…
AstraZeneca‘s stock jumped as much as 4% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment Tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease in both former smokers and in the overall population versus placebo, the company said. “This marks a notable…
Investors may want to take a step back as stocks swing amid rising geopolitical tensions. DBi’s Andrew Beer suggests the market’s crystal ball is broken. “It’s not normal for big markets to move as much as they are right now,” the firm’s managing member told CNBC’s “ETF Edge” this week. “Something is deeply wrong in…
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. If you’re as fascinated by the retail sector as I am, you’ll want to read this exclusive from CNBC’s Melissa Repko. I don’t want to spoil it, so just I’ll say that Target isn’t over its boycott woes. Stock futures…
NEW YORK — Nobody could’ve predicted the first Citi Field standing ovation of the season would be for Paul Skenes. The new-look Mets lineup pummeled the reigning National League Cy Young award winner, with contributions from fresh and familiar faces alike, in an 11-7 win over the Pirates on a sunny Opening Day in Flushing….
